increase in production costs; Why is injecting billions of dollars into the drug market not a solution? Mohammad Hashemi in an interview with "Iran": despite the 28% increase in the supply of drugs this year and reaching almost 3 billion 300 million dollars, the spokesperson of the Food and Drug Organization emphasized that this nominal increase does not mean an increase in the amount of drugs that can be supplied to patients. The global inflation of the purchase costs of raw materials, manufactured drugs, transportation and the costs involved in production and import eats up a major part of these foreign exchange resources so that only last year's quota can be prepared with new prices. The difference between "allocated currency" and "currency provided and paid at the right time" is the main key to solving the crisis, and for the stability of the supply of medicines, the timing of the allocation of resources to the pharmaceutical companies is of vital importance. Read the full text here.

increase in production costs; Why is injecting billions of dollars into the drug market not a solution? Mohammad Hashemi in an interview with "Iran": despite the 28% increase in the supply of drugs this year and reaching almost 3 billion 300 million dollars, the spokesperson of the Food and Drug Organization emphasized that this nominal increase does not mean an increase in the amount of drugs that can be supplied to patients. The global inflation of the purchase costs of raw materials, manufactured drugs, transportation and the costs involved in production and import eats up a major part of these foreign exchange resources so that only last year's quota can be prepared with new prices. The difference between "allocated currency" and "currency provided and paid at the right time" is the main key to solving the crisis, and for the stability of the supply of medicines, the timing of the allocation of resources to the pharmaceutical companies is of vital importance. Read the full text here.